Mark D Peterson1, Ananda Sen, Paul M Gordon. 1. Laboratory for Physical Activity and Exercise Intervention Research, Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI 48108, USA. mdpeterz@med.umich.edu
Abstract
PURPOSE: sarcopenia plays a principal role in the pathogenesis of frailty and functional impairment that occur with aging. There are few published accounts that examine the overall benefit of resistance exercise (RE) for lean body mass (LBM) while considering a continuum of dosage schemes and/or age ranges. Therefore, the purpose of this meta-analysis was to determine the effects of RE on LBM in older men and women while taking these factors into consideration. METHODS: this study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations. Randomized controlled trials and randomized or nonrandomized studies among adults ≥ 50 yr were included. Heterogeneity between studies was assessed using the Cochran Q and the I statistics, and publication bias was evaluated through physical inspection of funnel plots as well as formal rank-correlation statistics. Mixed-effects meta-regression was incorporated to assess the relationship between RE dosage and changes in LBM. RESULTS: data from 49 studies, representing a total of 1328 participants, were pooled using random-effect models. Results demonstrated a positive effect for LBM, and there was no evidence of publication bias. The Cochran Q statistic for heterogeneity was 497.8, which was significant (P < 0.01). Likewise, I was equal to 84%, representing rejection of the null hypothesis of homogeneity. The weighted pooled estimate of mean LBM change was 1.1 kg (95% confidence interval = 0.9-1.2 kg). Meta-regression revealed that higher-volume interventions were associated (β = 0.05, P < 0.01) with significantly greater increases in LBM, whereas older individuals experienced less increase (β = -0.03, P = 0.01). CONCLUSIONS: RE is effective for eliciting gains in LBM among aging adults, particularly with higher-volume programs. Findings suggest that RE participation earlier in life may provide superior effectiveness.
PURPOSE:sarcopenia plays a principal role in the pathogenesis of frailty and functional impairment that occur with aging. There are few published accounts that examine the overall benefit of resistance exercise (RE) for lean body mass (LBM) while considering a continuum of dosage schemes and/or age ranges. Therefore, the purpose of this meta-analysis was to determine the effects of RE on LBM in older men and women while taking these factors into consideration. METHODS: this study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations. Randomized controlled trials and randomized or nonrandomized studies among adults ≥ 50 yr were included. Heterogeneity between studies was assessed using the Cochran Q and the I statistics, and publication bias was evaluated through physical inspection of funnel plots as well as formal rank-correlation statistics. Mixed-effects meta-regression was incorporated to assess the relationship between RE dosage and changes in LBM. RESULTS: data from 49 studies, representing a total of 1328 participants, were pooled using random-effect models. Results demonstrated a positive effect for LBM, and there was no evidence of publication bias. The Cochran Q statistic for heterogeneity was 497.8, which was significant (P < 0.01). Likewise, I was equal to 84%, representing rejection of the null hypothesis of homogeneity. The weighted pooled estimate of mean LBM change was 1.1 kg (95% confidence interval = 0.9-1.2 kg). Meta-regression revealed that higher-volume interventions were associated (β = 0.05, P < 0.01) with significantly greater increases in LBM, whereas older individuals experienced less increase (β = -0.03, P = 0.01). CONCLUSIONS: RE is effective for eliciting gains in LBM among aging adults, particularly with higher-volume programs. Findings suggest that RE participation earlier in life may provide superior effectiveness.
Authors: Marieke B Snijder; Ronald M A Henry; Marjolein Visser; Jacqueline M Dekker; Jacob C Seidell; Isabel Ferreira; Lex M Bouter; John S Yudkin; Nico Westerhof; Coen D A Stehouwer Journal: J Hypertens Date: 2004-12 Impact factor: 4.844
Authors: Matthew J Delmonico; Robert E Ferrell; Anish Meerasahib; Greg F Martel; Stephen M Roth; Matthew C Kostek; Ben F Hurley Journal: J Am Geriatr Soc Date: 2005-02 Impact factor: 5.562
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Matthew J Delmonico; Tamara B Harris; Marjolein Visser; Seok Won Park; Molly B Conroy; Pedro Velasquez-Mieyer; Robert Boudreau; Todd M Manini; Michael Nevitt; Anne B Newman; Bret H Goodpaster Journal: Am J Clin Nutr Date: 2009-10-28 Impact factor: 7.045
Authors: S Verschueren; E Gielen; T W O'Neill; S R Pye; J E Adams; K A Ward; F C Wu; P Szulc; M Laurent; F Claessens; D Vanderschueren; S Boonen Journal: Osteoporos Int Date: 2012-07-10 Impact factor: 4.507
Authors: D Beckwée; A Delaere; S Aelbrecht; V Baert; C Beaudart; O Bruyere; M de Saint-Hubert; I Bautmans Journal: J Nutr Health Aging Date: 2019 Impact factor: 4.075
Authors: A A Mero; J J Hulmi; H Salmijärvi; M Katajavuori; M Haverinen; J Holviala; T Ridanpää; K Häkkinen; V Kovanen; J P Ahtiainen; H Selänne Journal: Eur J Appl Physiol Date: 2012-08-17 Impact factor: 3.078
Authors: Melissa M Markofski; Kristofer Jennings; Kyle L Timmerman; Jared M Dickinson; Christopher S Fry; Michael S Borack; Paul T Reidy; Rachel R Deer; Amanda Randolph; Blake B Rasmussen; Elena Volpi Journal: J Gerontol A Biol Sci Med Sci Date: 2019-09-15 Impact factor: 6.053
Authors: Kerry L Hildreth; Daniel W Barry; Kerrie L Moreau; Joseph Vande Griend; Randall B Meacham; Tammie Nakamura; Pamela Wolfe; Wendy M Kohrt; J Mark Ruscin; John Kittelson; M Elaine Cress; Robert Ballard; Robert S Schwartz Journal: J Clin Endocrinol Metab Date: 2013-03-26 Impact factor: 5.958